Ciprofibrate is a long-acting fibric acid derivative that activates peroxisome proliferator-activated receptor alpha (PPAR-α), reducing triglycerides and elevating HDL cholesterol. Its extended half-life supports convenient once-daily dosing.
Indicated for severe hypertriglyceridaemia with or without low HDL, and mixed dyslipidaemia in patients where statins are contraindicated or not tolerated, or as adjunctive therapy to statins in patients with mixed dyslipidaemia at high cardiovascular risk.
The content on this website is for general informational purposes only. While we strive for accuracy, RV Group makes no warranties regarding the completeness, reliability, or suitability of the information. For detailed product specifications, regulatory documentation, or inquiries, please contact us directly.
This product is a high-quality pharmaceutical formulation designed to meet strict global standards for safety, efficacy, and consistency. It is manufactured in compliance with international regulatory guidelines, ensuring reliability across diverse healthcare settings. Widely used by hospitals, specialty clinics, and healthcare providers, this medicine plays a critical role in managing specific medical conditions where precision treatment is essential. With assured sourcing and proper documentation, it supports seamless supply across regulated and emerging markets worldwide.
This medication is prescribed for targeted therapeutic use based on clinical requirements and patient condition. It should always be administered under the supervision of a qualified healthcare professional. Typical usage includes: Condition-specific treatment as per approved indications Hospital and specialty care settings Long-term or short-term therapy depending on protocol Dosage, frequency, and duration vary based on patient profile, disease severity, and medical guidelines. Always refer to official prescribing information before use.
This product follows stringent quality and pharmacovigilance standards to ensure patient safety and treatment effectiveness. Key safety considerations: Must be used strictly under medical supervision Possible side effects depend on patient condition and dosage Contraindications and precautions should be reviewed before use Monitoring may be required during treatment All safety data aligns with approved regulatory documentation and clinical guidelines.
Pricing for this product may vary based on: Order quantity (bulk vs small supply) Destination country and regulatory requirements Packaging and logistics conditions (cold chain, special handling) For accurate and competitive pricing, please request a customized quotation. We ensure transparent pricing aligned with global pharmaceutical distribution standards.
We go beyond supply — we enable reliable global access to critical medicines. What sets us apart: WHO-GSDP compliant sourcing and distribution Access to specialty, rare, and high-value medicines Strong global logistics network across 180+ countries Complete regulatory support including documentation and compliance Fast turnaround and secure supply chain management Our expertise ensures that every order is delivered safely, compliantly, and on time — anywhere in the world.
Our Ciprofibrate Tablets 100 mg are also Available for